BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37914769)

  • 1. Performance of serum soluble interleukin-2 receptor as a diagnostic marker for lymphoma in patients with fever.
    Kanda N; Yamaguchi R; Yamamoto Y; Matsumura M; Hatakeyama S
    Sci Rep; 2023 Nov; 13(1):18784. PubMed ID: 37914769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Serum-Soluble Interleukin 2 Receptor Levels vs Angiotensin-Converting Enzyme in Patients With Sarcoidosis-Associated Uveitis.
    Groen-Hakan F; Eurelings L; ten Berge JC; van Laar J; Ramakers CRB; Dik WA; Rothova A
    JAMA Ophthalmol; 2017 Dec; 135(12):1352-1358. PubMed ID: 29121154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Serum Soluble Interleukin-2 Receptor Levels for Differentiating between PCNSL and SCNSL.
    Mitobe Y; Matsuda KI; Sonoda Y
    Neurol Med Chir (Tokyo); 2023 Mar; 63(3):111-115. PubMed ID: 36682790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sIL-2R: A Novel Diagnostic Biomarker for Primary Adrenal Lymphoma.
    Yu K; Xie W; Zhao L; Wang H; Ren Y; Zheng C; Chen X; Su Z; Tang Y; Zhou F; Tian H; Zhu Y; Chen T
    J Clin Endocrinol Metab; 2022 May; 107(6):e2284-e2290. PubMed ID: 35254444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis.
    Eurelings LEM; Miedema JR; Dalm VASH; van Daele PLA; van Hagen PM; van Laar JAM; Dik WA
    PLoS One; 2019; 14(10):e0223897. PubMed ID: 31622413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study.
    Morita-Fujita M; Katoh D; Shimomura Y; Ishikawa T
    Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e337-e342. PubMed ID: 31053551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble interleukin-2 receptor level at diagnosis predicts transformation in patients with follicular lymphoma.
    Umino K; Fujiwara SI; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Muroi K; Kanda Y
    Leuk Lymphoma; 2017 Feb; 58(2):316-323. PubMed ID: 27267694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the absolute lymphocyte count/absolute monocyte count ratio, soluble interleukin 2 receptor level, serum programmed cell death 1 level, and the prognosis of patients with diffuse large B-cell lymphoma.
    Li C; Li W; Xu G; You M; Wu W; Kuang L
    Ann Palliat Med; 2021 Oct; 10(10):10938-10945. PubMed ID: 34763456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
    Naymagon L; Tremblay D; Troy K; Mascarenhas J
    Eur J Haematol; 2020 Sep; 105(3):255-261. PubMed ID: 32353917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH.
    Hayden A; Lin M; Park S; Pudek M; Schneider M; Jordan MB; Mattman A; Chen LYC
    Blood Adv; 2017 Dec; 1(26):2529-2534. PubMed ID: 29296904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of serum soluble interleukin-2 receptor level at diagnosis in elderly patients with diffuse large B-cell lymphoma treated with R-CHOP.
    Umino K; Fujiwara SI; Minakata D; Yamamoto C; Meguro A; Matsuyama T; Sato K; Ohmine K; Izumi T; Muroi K; Kanda Y
    Leuk Lymphoma; 2019 Mar; 60(3):734-741. PubMed ID: 30188236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum and vitreous soluble interleukin-2 receptor in patients with intraocular lymphoma.
    Suzuki K; Namba K; Kase S; Ogino Y; Hase K; Iwata D; Mizuuchi K; Hiraoka M; Kitaichi N; Ishida S
    BMC Ophthalmol; 2022 Nov; 22(1):428. PubMed ID: 36357882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on
    Senjo H; Kanaya M; Izumiyama K; Minauchi K; Hirata K; Mori A; Saito M; Tanaka M; Iijima H; Tsukamoto E; Itoh K; Ota S; Morioka M; Hashimoto D; Teshima T;
    Cancer Med; 2019 Mar; 8(3):953-962. PubMed ID: 30790452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble interleukin-2 receptor (sIL-2R) is an accurate biomarker for dengue-associated hemophagocytic lymphohistiocytosis syndrome diagnosed by Hscore.
    Mahabala C; Koushik VK; Manjrekar PA; Balanthimogru P
    Infection; 2023 Apr; 51(2):433-438. PubMed ID: 35999341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between levels of serum gastric inhibitory polypeptide (GIP), soluble interleukin-2 receptor (sIL-2R), and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and disease condition and prognosis of patients with severe acute pancreatitis.
    Zeng L; Xi F; Yang Y; Guo L; Hu H; Yang Q; Ma Q
    Ann Palliat Med; 2021 Jun; 10(6):6786-6792. PubMed ID: 34154356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 2 receptor is risk for sarcopenia in Men with high fracture risk.
    Ge J; Zeng J; Li N; Ma H; Zhao Z; Sun S; Jing Y; Qian C; Fei Z; Qu S; Cui R; Sheng H
    J Orthop Translat; 2023 Jan; 38():213-219. PubMed ID: 36439626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement and cellular sources of the soluble interleukin-2 receptor in primary central nervous system lymphoma.
    Kitai R; Sasaki H; Matsuda K; Tsunetoshi K; Yamauchi T; Neishi H; Matsumura K; Tsunoda A; Takeuchi H; Sato K; Kikuta K
    Brain Tumor Pathol; 2013 Jan; 30(1):34-9. PubMed ID: 22399193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of soluble interlukin-2 receptor level at diagnosis on the outcome for patients with classical Hodgkin lymphoma treated with ABVD with or without radiotherapy.
    Umino K; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Ann Hematol; 2019 Sep; 98(9):2121-2129. PubMed ID: 31240469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
    Wieland CW; Vogl T; Ordelman A; Vloedgraven HG; Verwoolde LH; Rensen JM; Roth J; Boer J; Hessels J
    Br J Dermatol; 2013 Jun; 168(6):1252-8. PubMed ID: 23320892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Soluble Interleukin-2 Receptor Is a Biomarker for Pneumocystis jirovecii Pneumonia among Patients with Rheumatoid Arthritis under Methotrexate Therapy.
    Sakamoto N; Hara S; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kakugawa T; Yamaguchi H; Obase Y; Kushima H; Ishii H; Noguchi S; Kido T; Kobayashi T; Soejima Y; Yoshioka S; Ishimatsu Y; Yatera K; Kadota JI; Mukae H
    Tohoku J Exp Med; 2019 Jul; 248(3):209-216. PubMed ID: 31366819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.